Pharmacoeconomics of outpatient treatment of lower airways infectious diseases
Abstract
Ampicillin, cotrimoxazole (Biseptol) and azithromycin (Sumamed) were applied for outpatient treatment of 90 patients with lower airways infection. The study consisted of comparison of clinical efficacy and pharmacoeconomic analysis by the "cost-effectiveness" method. The clinical efficacy was 80, 67 and 97% for ampicillin, Biseptol and Sumamed correspondingly. The best tolerability was noted for Sumamed. The pharmacoeconomic effectiveness of the therapy was evaluated as the ratio of the cost and the number of both recovering and improved patients and it was 372, 656 and 366 rubles per a convalescent for ampicillin, Biseptol and Sumamed accordingly.
About the Authors
Yu. B. Belousov
Кафедра клинической фармакологии Российского государственного медицинского университета;
городская поликлиника №42
Russian Federation
Russian Federation
S. S. Shmat
Кафедра клинической фармакологии Российского государственного медицинского университета;
городская поликлиника №42
Russian Federation
Russian Federation
T. G. Selevina
Кафедра клинической фармакологии Российского государственного медицинского университета;
городская поликлиника №42
Russian Federation
Russian Federation
O. V. Efremenkova
Кафедра клинической фармакологии Российского государственного медицинского университета;
городская поликлиника №42
Russian Federation
Russian Federation
References
1. Европейское общество клинической микробиологии и инфекционных болезней. Европейское руководство по клинической оценке противоинфекционных лекарственных средств. / Под ред. Beam Т. et al.- Смоленск, 1996.
2. Ball P., Make В. Acute exacerbation of chronic bronchitis: an international comparison / / Chest.- 1998.- Vol. 113 (3).- P. 199-204.
3. Brown P.D., Lerner S.A. Community-acquired pneumonia / / Lancet - 1998 - Vol.352 - P.1295-1302.
4. Carbon C., Bax R. Regulating the use of antibiotics in the community / / B M J.- 1998 - Vol.317 - P.663-665.
5. Neu H.C., Young L.S., Zinner S.H., eds. The new macrolides, azalides and streptogramins, pharmacology and clinical applications. New York: Marsel Dekker, 1993.
Review
For citations:
Belousov Yu.B., Shmat S.S., Selevina T.G., Efremenkova O.V. Pharmacoeconomics of outpatient treatment of lower airways infectious diseases. PULMONOLOGIYA. 2000;(3):77-79. (In Russ.)
Views:
668
Email this article 